Back
Solid Biosciences, Inc. 10K Form
Buy
56
SLDB
Solid Biosciences, Inc.
Last Price:
$5.92
Seasonality Move:
29.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | SLDB/Solid Biosciences, Inc. Quarterly |
| 2020-05-07 | 10Q | SLDB/Solid Biosciences, Inc. Quarterly |
| 2020-03-13 | 10K | SLDB/Solid Biosciences, Inc. Annual |
| 2020-03-12 | 10K | SLDB/Solid Biosciences, Inc. Annual |
| 2019-11-12 | 10Q | SLDB/Solid Biosciences, Inc. Quarterly |
| 2019-08-14 | 10Q | SLDB/Solid Biosciences, Inc. Quarterly |
Receive SLDB News And Ratings
See the #1 stock for the next 7 days that we like better than SLDB
SLDB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-33.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.80 |
| Price / Book: | 2.12 |
Profitability
| EPS (TTM): | -2.49370 |
|---|---|
| Net Income (TTM): | $-167.1M |
| Gross Margin: | $-2.5M |
| Return on Equity: | -77.74% |
| Return on Assets: | -62.99% |
Solid Biosciences, Inc. Earnings Forecast
Key Solid Biosciences, Inc. Financial Ratios
-
Per Share Earnings over the last 10 years have been positive in 5 years.
Solid Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SLDB |
| CUSIP: | 83422E |
| Website: | solidbio.com |
Debt
| Debt-to-Equity Ratio: | 0.1 |
|---|---|
| Current Ratio: | 6.74 |
| Quick Ratio: | 6.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SLDB Technical Analysis vs Fundamental Analysis
Buy
56
Solid Biosciences, Inc. (SLDB)
is a Buy
Is Solid Biosciences, Inc. a Buy or a Sell?
-
Solid Biosciences, Inc. stock is rated a BuyThe current Solid Biosciences, Inc. [SLDB] share price is $5.92. The Score for SLDB is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.